Cite
HARVARD Citation
de la Torre-Aláez, M. et al. (2022). Nivolumab after selective internal radiation therapy for the treatment of hepatocellular carcinoma: a phase 2, single-arm study. Journal for immunotherapy of cancer. 10 (11), p. . [Online].